Qiming Venture Partners

Qiming Venture Partners is a leading global venture capital firm managing multiple US Dollar and RMB funds with over $9.5 billion in capital raised. They focus on early and growth-stage investments in Technology & Consumer and Healthcare sectors, boasting a portfolio of influential companies.

Qiming Venture Partners favicon
Founded 2006 · Venture Capital
Shanghai (China), Beijing (China), Hong Kong ([object Object]), Suzhou (China), Singapore ([object Object])
Investment Stages
Series A
Series B
Markets
Technology and Consumer (T&C)
Healthcare
Information technology
New consumer business patterns
Mobile internet
Social networking
Entertainment
Artificial intelligence
Robotics
Semiconductors
Enterprise software
Blockchain
Manufacturing
Diagnostics
R&D
Medical equipment
Medical services
Digital Healthcare
Portfolio Companies

Xiaomi, Meituan, Bilibili, Zhihu, Roborock, UBTech, WeRide, Gan & Lee Pharmaceuticals, Tigermed, Zai Lab, CanSino Biologics, Schrödinger, APT Medical, New Horizon Health, Sanyou Medical, AmoyDx, Berry Genomics, SinocellTech, Yuanxin Technology, Caidya, Belief BioMed, HyperStrong, WeDoctor, Dianping, Tigermed, ZaiLab, UBTech, Berry Genomics, CooTek, Sinocelltech, Tongdun, Tellgen, Unisound, Cansinotech, Mafengwo, Meitu, Bilibili, Roborock, Miaoshou Doctor, Transwarp, Tujia

Links
Website Team Page Portfolio LinkedIn X Crunchbase PitchBook
Related VC firms in China
6 Dimensions Capital favicon
6 Dimensions Capital
Life Sciences, Healthcare
Aera VC favicon
Aera VC
Climate, Frontier, Deep tech, Sustainability
Artesian favicon
Artesian
Agrifood, Clean Energy, Medtech, Software, Hardware, AI, Robotics
Share this page